JPWO2023053384A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2023053384A5 JPWO2023053384A5 JP2023550943A JP2023550943A JPWO2023053384A5 JP WO2023053384 A5 JPWO2023053384 A5 JP WO2023053384A5 JP 2023550943 A JP2023550943 A JP 2023550943A JP 2023550943 A JP2023550943 A JP 2023550943A JP WO2023053384 A5 JPWO2023053384 A5 JP WO2023053384A5
- Authority
- JP
- Japan
- Prior art keywords
- fatty liver
- pharmaceutical composition
- amino acid
- acid sequence
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP2021/036238 WO2023053384A1 (ja) | 2021-09-30 | 2021-09-30 | 脂肪肝および非アルコール性脂肪肝炎の治療薬 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2023053384A1 JPWO2023053384A1 (https=) | 2023-04-06 |
| JPWO2023053384A5 true JPWO2023053384A5 (https=) | 2024-10-07 |
| JP7798300B2 JP7798300B2 (ja) | 2026-01-14 |
Family
ID=85781770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023550943A Active JP7798300B2 (ja) | 2021-09-30 | 2021-09-30 | 脂肪肝および非アルコール性脂肪肝炎の治療薬 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240299496A1 (https=) |
| EP (1) | EP4410302A4 (https=) |
| JP (1) | JP7798300B2 (https=) |
| KR (1) | KR20240070640A (https=) |
| CN (1) | CN118317780A (https=) |
| AU (1) | AU2021466375A1 (https=) |
| CA (1) | CA3233234A1 (https=) |
| MX (1) | MX2024003974A (https=) |
| WO (2) | WO2023053384A1 (https=) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3358011T (pt) | 2011-04-26 | 2020-04-23 | Univ Osaka | Péptido para induzir a regeneração de um tecido e a sua utilização |
| US20200038486A1 (en) | 2017-04-07 | 2020-02-06 | StemRIM Inc. | Therapeutic medicine for fibrous disease |
| EP3728593A1 (en) * | 2017-12-18 | 2020-10-28 | Alnylam Pharmaceuticals, Inc. | High mobility group box-1 (hmgb1) irna compositions and methods of use thereof |
| US11684653B2 (en) * | 2019-03-06 | 2023-06-27 | The Cleveland Clinic Foundation | Compositions and method for reducing virulence of microorganisms |
-
2021
- 2021-09-30 AU AU2021466375A patent/AU2021466375A1/en active Pending
- 2021-09-30 CA CA3233234A patent/CA3233234A1/en active Pending
- 2021-09-30 WO PCT/JP2021/036238 patent/WO2023053384A1/ja not_active Ceased
- 2021-09-30 KR KR1020247014019A patent/KR20240070640A/ko active Pending
- 2021-09-30 JP JP2023550943A patent/JP7798300B2/ja active Active
-
2022
- 2022-09-30 MX MX2024003974A patent/MX2024003974A/es unknown
- 2022-09-30 EP EP22876529.3A patent/EP4410302A4/en active Pending
- 2022-09-30 WO PCT/JP2022/036662 patent/WO2023054666A1/ja not_active Ceased
- 2022-09-30 CN CN202280078804.6A patent/CN118317780A/zh active Pending
- 2022-09-30 US US18/697,330 patent/US20240299496A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022501040A5 (https=) | ||
| JP2026041749A5 (https=) | ||
| JPWO2019107530A5 (https=) | ||
| JP2961045B2 (ja) | 腸管粘膜増強促進剤 | |
| CN101405020A (zh) | 代谢疾病治疗中的内皮素和内皮素受体激动剂 | |
| EP4294210B1 (en) | Methods and compositions using combinations of lactobacillus mucosae and soluble dietary fiber | |
| Lee et al. | Recombinant Lactococcus lactis Expressing Ling Zhi 8 Protein Ameliorates Nonalcoholic Fatty Liver and Early Atherogenesis in Cholesterol‐Fed Rabbits | |
| TW200803751A (en) | Use of a protein hydrolysate for enhancing activity of glucagon-like peptide-1 | |
| JP6440843B2 (ja) | 脂肪代謝の調節に供する医薬品の製造のための第一鉄アミノ酸キレートを含む組成物の使用 | |
| EP2196211B1 (en) | Apolactoferrin compositions for use in treating viral hepatitis c | |
| JPWO2023053384A5 (https=) | ||
| JP2025511854A5 (https=) | ||
| CN113993883A (zh) | 一种多肽及其应用 | |
| WO2001068085A1 (en) | A method for stimulation of defensin production | |
| JP2022513626A5 (https=) | ||
| TWI911432B (zh) | 含有多種多套胜肽的重組蛋白質、含有該重組蛋白質的醫藥組成物以及該重組蛋白質之製備方法 | |
| WO2024206740A1 (en) | Methods and uses for treating nausea and emesis | |
| JP2024516605A5 (https=) | ||
| IL315941A (en) | Uses of farnesoid x receptor agonists | |
| CN103285406B (zh) | microRNA-203及其拟似物在制备防治肥胖、血脂异常及其并发症药物中的应用 | |
| JP2023517629A (ja) | 胎盤抽出物を含む肝疾患の予防または治療用および肝機能改善用組成物 | |
| JP2000336038A (ja) | 肝臓保護剤 | |
| JP7623645B2 (ja) | 新規低分子ペプチド及びその代謝異常関連脂肪肝を拮抗させる用途 | |
| CN117717601B (zh) | 一种多肽在制备治疗或预防非酒精性脂肪肝药物中的应用 | |
| JP2009221162A (ja) | ラクトフェリンを有効成分とするｕｃｐ発現促進剤 |